APASL 2026
Overview
The single best venue to reach the Asia-Pacific hepatology community — a region with the world's highest HBV burden and rapidly growing NASH/MASH prevalence. Companies with a regional Asia-Pacific commercial strategy should prioritize this.
Key Facts
- Host organization: Asian Pacific Association for the Study of the Liver
- Primary specialty: hepatology
- Scale: mid
- Geography: Asia-Pacific
- International attendance: ~90%
Best For
Buyer Stage Fit
Booth Costs
Booth pricing not yet verified for APASL. Request our research →
All-In Cost Estimate (10×10 Inline)
| Space rental | — |
| Drayage | $1,200 – $2,500 |
| Electrical (20A) | $300 – $450 |
| Carpet/padding | $200 – $400 |
| Cleaning (3 days) | $150 – $250 |
| Lead retrieval (1 unit) | $400 – $900 |
| Wi-Fi | $500 – $1,500 |
| Estimated total | $7,000 – $14,000 |
Does not include travel, staffing, booth display, or marketing materials.
Audience
Asian Pacific hepatologists, with growing global participation. HBV is the dominant disease focus reflecting regional epidemiology.
- Purchasing authority: ~45% of attendees
- Effective buyers: ~2,250
- Cost per effective buyer: $4.67 ($10,500 all-in ÷ 2,250 buyers)
- International attendance: ~90%
Venue & Logistics
- Venue: Various Asian capitals (rotates)
- Management company: Varies by host country
- Product theater: Available
Who Else Exhibits
Approximately 60+ exhibitors typically attend APASL. Your competitors are here.
Our Take
Why Exhibit
The single best venue to reach the Asia-Pacific hepatology community — a region with the world's highest HBV burden and rapidly growing NASH/MASH prevalence. Companies with a regional Asia-Pacific commercial strategy should prioritize this.
Why Skip
Skip if your commercial strategy is purely US/Europe — APASL audiences are predominantly local-Asian and conversions require regional regulatory and distribution presence.
Insider Tips
Logistics vary by host country — budget extra for shipping, customs, and translation if needed. Korean and Japanese host cities tend to have stronger industry infrastructure than newer hosts.
Buzzbox Score: 8.0 / 10 (Excellent)
8.0 out of 10. A top-tier show worth a serious line item. Carried by cost efficiency (9.5: $20/sqft, under the $39 median). The lightest dimension is editorial value (7.0, "who should skip" note included). The single best venue to reach the Asia-Pacific hepatology community, a region with the world's highest HBV burden and rapidly growing NASH/MASH prevalence.
How we score
Six weighted factors, each scored on a 0 to 100 rubric then normalized to a 7.0 to 10.0 band. Every show on this list cleared a relevance bar to be included, so 7.0 is the floor; the number tells you how far the leaders pull ahead.
Strong (8.2): 45% purchasing authority (moderate) and 83:1 attendee ratio.
Standout (9.5): $20/sqft, under the $39 median.
Solid (7.6): booth pricing published, exhibitor count disclosed, and attendee purchasing-authority data published.
Strong (8.0): managed by Varies by host country, non-union venue (simpler, cheaper move-in), and product theater / demo stage available.
Solid (7.0): "who should skip" note included, product-theater opportunity for thought leadership, and fits multiple buyer-journey stages.
Strong (8.5): mid-size with room to grow and growing year over year.
Key Deadlines
Detailed deadlines not yet verified for APASL. Check the official site for the application window.
Frequently Asked Questions
How much does a booth cost at APASL?
An all-in 10×10 booth at APASL runs roughly $7,000–$14,000, including space rental, drayage, electrical, carpet, and basic services. Travel, staffing, and booth display are additional.
How many people attend APASL?
APASL draws approximately 5,000 attendees. Asian Pacific hepatologists, with growing global participation. HBV is the dominant disease focus reflecting regional epidemiology.
When is APASL ?
APASL is scheduled for March 25-29, 2026. Location: Various Asian capitals (rotates).
Is APASL worth exhibiting at?
The single best venue to reach the Asia-Pacific hepatology community — a region with the world's highest HBV burden and rapidly growing NASH/MASH prevalence. Companies with a regional Asia-Pacific commercial strategy should prioritize this..